Become a Member
Israel

Israeli study: South African variant can 'break through' Pfizer vaccine

Tel Aviv University researchers release results of study of vaccinated and unvaccinated people, cautioning over findings given the small number of Israelis with the variant

April 11, 2021 13:35
Covid.new jpg.jpg
1 min read

A new Israeli study suggests that the South African Covid variant can “break through” the Pfizer vaccine.

Tel Aviv University researchers studied 400 people who tested positive for Covid-19 after being vaccinated at least two weeks previously and the same number of unvaccinated people with the virus.

The South African variant accounted for around 1 per cent of the cases studied.

But among patients who had received two doses of the vaccine, the variant's prevalence was eight times higher than among those unvaccinated - 5.4 per cent compared to 0.7 per cent.